Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer. Li N, Wang BX, Li J, Shao Y, et al. Cancer 2022;128:708-718.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Li N, Wang BX, Li J, Shao Y, et al. Perioperative circulating tumor DNA as a potential prognostic marker for operable stage I to IIIA non-small cell lung cancer. Cancer 2022;128:708-718.
PMID: 35076939